Skip to content
Open access

Urolithin A Exerts Neuroprotective Effects Against Ischemic Stroke by Inhibiting Oxidative Stress and Neuroinflammation

Aug 2026 · CNS Neuroscience & Therapeutics · Vol 32 · 0 citations · 54 references
Medicine

Abstract

Ischemic stroke (IS), the main stroke type, causes neuronal injury via hypoperfusion and hypoxia, imposes heavy health burdens, and is characterized by neurological deficits driven by oxidative stress and inflammation.

Read PDF

Similar papers

Open access Aug 2026

Cholesterol Drives IFITM3 + Microglia Activation and Induces STING Mediated Neuroinflammation After Ischemic Stroke

Cerebral ischemic stroke triggers extensive neuronal membrane breakdown, releasing a massive load of cholesterol that overwhelms resident microglia. Dysregulated microglial cholesterol metabolism has been implicated in post‐stroke neuroinflammation, yet the specific pathogenic microglial subpopulations, their molecular...

Yue-lei Cheng, Yuxi Zhou, Yong-Hui Chen et al. · 0 citations
Editorial Open access Aug 2026

Editorial for the Special Issue “Molecular Mechanisms and Treatment of Ischemia–Reperfusion Injury”

Ischemia-reperfusion injury (IRI) remains one of the most challenging obstacles in modern medicine, influencing outcomes across cardiovascular disease, organ transplantation, stroke, peripheral ischemia, and acute surgical conditions [...].

Jun Kobayashi · 0 citations
Open access Aug 2026

Scutellarin Alleviates Neuronal Apoptosis After Ischemia and Hypoxia via the HIF‐1α–CX3CR1 Axis

Stroke is a significant health threat characterized by high incidence, mortality, disability, recurrence, and complications. Over 70% of strokes are ischemic in nature. Reducing neuronal apoptosis following ischemic–hypoxic injury is crucial for effective treatment. This study investigates the direct neuroprotective ef...

Jing-Chun Pei, Bin Hu, Zhong-Hui Wen et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.